MRKR Stock Summary and Trading Ideas (Marker Therapeutics | NASDAQ:MRKR)

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

Marker Therapeutics trades on the NASDAQ stock market under the symbol MRKR.

As of May 12, 2026, MRKR stock price declined to $1.44 with 47,678 million shares trading.

MRKR has a beta of 1.51, meaning it tends to be more sensitive to market movements. MRKR has a correlation of 0.05 to the broad based SPY ETF.

MRKR has a market cap of $24.01 million. This is considered a Sub-Micro Cap stock.

Last quarter Marker Therapeutics reported $1 million in Revenue and -$.09 earnings per share. This beat revenue expectation by $453,800 and exceeded earnings estimates by $.10.

In the last 3 years, MRKR traded as high as $9.68 and as low as $.81.

The top ETF exchange traded funds that MRKR belongs to (by Net Assets): VTI, VXF.

MRKR has underperformed the market in the last year with a price return of +24.1% while the SPY ETF gained +32.1%. MRKR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -1.4% and -0.7%, respectively, while the SPY returned +6.9% and +3.2%, respectively.

MRKR support price is $1.38 and resistance is $1.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MRKR shares will trade within this expected range on the day.